Studies wherein iPSCs from a DMD subject with a premature stop codon mutation were treated with read-through molecules44, demonstrated not only partial restoration of dystrophin expression in iPSC-derived astrocytes, but also correction of the defective glutamate handling and associated neural toxicity. This evidence concerns the gene DMD and Duchenne muscular dystrophy.